Evidence map›Paper›PMID 32295422›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2020

Macrophages Promote Aortic Valve Cell Calcification and Alter STAT3 Splicing.

Michael A Raddatz, Tessa Huffstater, Matthew R Bersi, Bradley I Reinfeld, Matthew Z Madden, Sabrina E Booton, W Kimryn Rathmell, Jeffrey C Rathmell, Brian R Lindman, Meena S Madhur and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Progress on long non-coding RNAs in calcific aortic valve disease.Frontiers in cardiovascular medicine · 2025
    Review
  9. Macrophages as key modulators of calcific aortic valve disease.Frontiers in cardiovascular medicine · 2025
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Michael A RaddatzFrom the Vanderbilt University School of Medicine (M.A.R., B.I.R., M.Z.M.), Vanderbilt University, Nashville, TN.
Tessa HuffstaterDepartment of Biomedical Engineering (M.A.R., T.H., M.R.B., S.E.B., W.D.M.), Vanderbilt University, Nashville, TN.
Matthew R BersiDepartment of Biomedical Engineering (M.A.R., T.H., M.R.B., S.E.B., W.D.M.), Vanderbilt University, Nashville, TN.
Bradley I ReinfeldFrom the Vanderbilt University School of Medicine (M.A.R., B.I.R., M.Z.M.), Vanderbilt University, Nashville, TN.
Matthew Z MaddenFrom the Vanderbilt University School of Medicine (M.A.R., B.I.R., M.Z.M.), Vanderbilt University, Nashville, TN.
Sabrina E BootonDepartment of Biomedical Engineering (M.A.R., T.H., M.R.B., S.E.B., W.D.M.), Vanderbilt University, Nashville, TN.
W Kimryn Rathmellthe Division of Hematology and Oncology, Department of Medicine (B.I.R., W.K.R.), Vanderbilt University Medical Center, Nashville, TN.
Jeffrey C RathmellDepartment of Pathology, Microbiology, and Immunology (M.Z.M., J.C.R.), Vanderbilt University Medical Center, Nashville, TN.
Brian R LindmanStructural Heart and Valve Center (B.R.L.), Vanderbilt University Medical Center, Nashville, TN.
Meena S MadhurDepartment of Molecular Physiology and Biophysics (M.S.M.), Vanderbilt University, Nashville, TN.
W David MerrymanDepartment of Biomedical Engineering (M.A.R., T.H., M.R.B., S.E.B., W.D.M.), Vanderbilt University, Nashville, TN.
Vanderbilt University · USVanderbilt University Medical Center · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
Mechanobiology of Cardiopulmonary FibrosisR35HL135790 · NHLBI · VANDERBILT UNIVERSITY · PI MERRYMAN, WILLIAM D · 2017 to 2023
$5.5M
Medical Scientist Training ProgramT32GM152284 · NIGMS · VANDERBILT UNIVERSITY · PI Christopher S. Williams · 2024 to 2026
$4.8M
Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory diseaseR01DK105550 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jeffrey C Rathmell · 2015 to 2026
$4.7M
Glycolysis and Glutaminase in CD8 T cell differentiation and anti-tumor immunityF30CA239367 · NCI · VANDERBILT UNIVERSITY · PI MADDEN, MATTHEW ZACHARY · 2020 to 2022
$130k
Immune cells and STAT3-mediated inflammation in calcific aortic valve diseaseF30HL147464 · NHLBI · VANDERBILT UNIVERSITY · PI RADDATZ, MICHAEL ASTON · 2020 to 2020
$22k
NCI NIH HHS F30 CA239367NHLBI NIH HHS F30 HL147464NHLBI NIH HHS R35 HL135790NIDDK NIH HHS R01 DK105550NIGMS NIH HHS T32 GM007347NIGMS NIH HHS T32 GM152284
6 · The paper itself

Abstract

objectiveMacrophages have been described in calcific aortic valve disease, but it is unclear if they promote or counteract calcification. We aimed to determine how macrophages are involved in calcification using the

conclusionsThis study reveals that

Indexed as

AnimalsAortic ValveAortic Valve StenosisBone Marrow TransplantationCalcinosisCell MovementCyclic S-OxidesDisease Models, AnimalGene ExpressionGenotypeHumansInflammationMacrophagesMaleMiceMice, Inbred C57BLCyclic S-OxidesNotch1 protein, mouseReceptor, Notch1Stat3 protein, mouseSTAT3 Transcription Factorstatticaortic valvehematopoietic systeminflammationmacrophagespathologic calcificationSTAT3 transcription factor

Identifiers

PMID32295422
PMCPMC7285853
OpenAlexW3017124409

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.